This Cell-El study cohort includes: Children (ages 2-18) diagnosed with ASD who are privately undergoing Stem Cell treatment (SCT) outside of Israel. Cell-El seeks to observe the effects of Stem Cell treatment on the biomarkers we have identified as possibly unique to ASD. We are studying how these Biomarkers change with the application of SCT. Included in the study are behavioral changes possibly observed in these children as well. (see our recent publication regarding our research on these biomarkers –  Autism Spectrum Disorder Diagnosis -using a New Panel of Immune- and Inflammatory-related Serum Biomarkers: A Case-Controlled Multicenter Study.

girl illustration

Cell-El has chosen to observe the changes in these biomarkers specifically after undergoing SCT as there has been preliminary evidence that stem cells can have an immune-modulating effect on the body. See:

Parents and clinicians have reported significant changes to the ASD related symptoms after SCT. Cell-El is now investigating if there is an underlying biomedical dysfunction prior to treatment as well as any treatment induced changes both biomedically and as evidenced by improved outward behaviors and symptoms.  We hope that Improving our understanding of the value of these biomarkers could lead to utilizing them as a  guide to diagnosis and perhaps even treatment choices for ASD.

Currently, Cell-El is not actively recruiting participants for this study.

Help Us Help You

Better diagnostics for ASD based on laboratory-measured objective biomarkers can possibly enable researchers and clinicians to provide more precise and personalized treatment. You too can make a difference in the lives of children with ASD and their families by joining the Cell-El study. Cell-El is recruiting mothers and their infants aged 10-18 months who have not been diagnosed with ASD but who have a sibling diagnosed with ASD.

Please contact Leah at [email protected] or fill out the form to find out about eligibility to participate in  our diagnostic study and please help spread the word about the Cell-El study. Sharing our study will enable our important biomarker diagnostic tool to be integrated into autism treatment as quickly as possible.